Assorted prescription medication packaging and tablets on a mint green background, relevant to ERISA lawsuit and prescription drug fraud discussions.

Goldman Sachs Faces CFTC Scrutiny Over Record-Keeping Violations

ERISA Lawsuit for Johnson & Johnson On February 5, 2024, a prescription drug fraud complaint was filed against Johnson & Johnson, as well as the company’s benefits committee for allegedly mismanaging its employee prescription drug benefit program. The case is a proposed class action filed in federal court by Johnson & Johnson’s Health Care Policy...

Jar of pink prescription pills spilling onto a wooden surface next to rolled-up hundred dollar bills, symbolizing prescription drug fraud related to Centene's settlement.

Centene & Pharmacy Benefit Manager Agree to Pay $215 Million to Settle Prescription Drug Fraud Scheme Allegations

On February 8, 2023, California Attorney General Rob Bonta announced that Centene Corporation agreed to pay $215 million to settle allegations that the company and its Pharmacy Benefit Manager violated the California False Claims Act by committing prescription drug fraud against Medi-Cal. Specifically, the California Department of Justice alleged that Centene submitted false reports of...

Red apple resting on a background of hundred-dollar bills, symbolizing financial rewards and whistleblower claims.

Young Law Group Secures Multi-Millon Dollar Reward for SEC Whistleblower Client In $97 Million Enforcement Action Against TIAA-CREF Subsidiary for Violations in Retirement Rollover Recommendations

Young Law Group, PC, announced today that it has secured a multi-million-dollar award on behalf of a whistleblower client resulting from the Securities and Exchange Commission’s $97 Million enforcement action against TIAA-CREF Individual & Institutional Services LLC, a subsidiary of Teachers Insurance and Annuity Association of America (TIAA). The SEC whistleblower case alleged that from...

Gavel resting on a pile of cash with white pills, symbolizing pharmacy fraud and legal settlements related to prescription drug violations.

Indiana Files PBM Fraud Case Against 6 PBMs and Drug Manufacturers for Inflating Insulin Prices

Indiana PBM Fraud On March 22, 2024, the Indiana Attorney General, Todd Rokita, announced that he is filing a suit against Pharmacy Benefit Managers (PBMs) and drug manufacturers for their part in raising the price of Insulin. This drug manufacturer and PBM fraud lawsuit follows multiple actions filed by other states on the same subject...

Robot seated in courtroom, symbolizing AI's role in legal proceedings related to fraud cases and regulatory actions.

Investment Advisors Pay $400,000 in Civil Penalties to Settle AI Fraud Case

On March 18, 2024, Delphia Inc. and Global Predictions Inc. paid $400,000 in civil penalties to settle SEC charges related to the two investment advisers misrepresenting the method by which they used artificial intelligence (AI) to support their efforts. The firms were each found to be in violation of the Advisers Act and the SEC‘s...

Digital scales of justice symbolizing legal integrity in cryptocurrency and fraud cases.

SEC Charges CryptoFX for $300 Million Ponzi Scheme

On March 14, 2024, the Securities and Exchange Commission (SEC) and their crypto fraud lawyer team charged 17 CryptoFX employees for allegedly carrying out a $300 million Ponzi scheme that focused on defrauding the Latino community and impacted more than 40,000 investors. These charges came after the SEC had already issued an emergency action in...

Gavel resting on money with white pills, symbolizing legal settlements in pharmaceutical cases related to opioid litigation.

Young Law Group Achieves $475 Million Settlement with Big Pharma Opioid Company

On February 28, 2024, opioid manufacturer, Endo Health Solutions Inc. (“Endo”), agreed to pay $475 million to settle U.S. v. Endo Int’l plc, Case No. 19-cv-80574, a qui tam action brought by an anonymous whistleblower, who Young Law Group represented, on behalf of the United States. The complaint alleged that the company had violated the...

Aerial view of colorful shipping containers stacked on a cargo ship, representing global trade and logistics related to recent SEC fraud charges.

Yakima Pays $3 Million for Violating Fair Trade Rules

On January 31, 2024, the United States Attorney’s Office of the Western District of Washington announced that Yakima Products, Inc. agreed to pay $3 million to settle allegations that the company violated the False Claims Act (FCA). Specifically, a former employee brought forth this case under the qui tam provision of the FCA alleging that...

Gavel resting on a circuit board, symbolizing legal proceedings and whistleblower cases related to technology and compliance.

Booz Allen Whistleblower Case Settled for $377.45 Million

Booz Allen Whistleblower Case: Uncovering Government Overcharging On July 21, 2023, Booz Allen Hamilton Holding Corporation (Booz Allen) agreed to pay $377.45 million to settle claims that the company billed the government and thus used taxpayer dollars for costs associated with non-government related work. The settlement in this Booz Allen whistleblower case is notably one...

Scales of justice balanced over a mound of white pills, symbolizing legal actions and settlements related to opioid cases and the False Claims Act.

Endo Pharmaceuticals Part of in $475M DOJ Settlement for Opioid False Claims Act Case filed by Young Law Group

Eric L. Young from Young Law Group, P.C. (YLG), representing an anonymous whistleblower, disclosed today that Endo Health Solutions, Inc. (“Endo”), has agreed to a civil settlement of $475 Million to resolve its civil liability under the federal False Claims Act by unlawfully promoting Opana ER, a dangerous opioid drug that was removed from the...

Category: News